Future Market Insights (FMI), a distinguished leader in market research and consulting, has announced a substantial growth forecast for the global anatomic pathology market. Following a valuation of USD 32.5 billion in 2022, the market is anticipated to expand at a remarkable compound annual growth rate (CAGR) of 8.2% from 2022 to 2030, ultimately reaching an estimated USD 61.1 billion by the end of the decade.
Anatomic pathology is pivotal in delivering accurate disease diagnoses and plays a vital role in the advancement of drug discovery and development. As the market continues to evolve, FMI stands poised to capitalize on this growth opportunity, leveraging its innovative methodologies and forward-thinking strategies to maintain its leadership position in this dynamic sector.
“We are enthusiastic about the immense potential within the global anatomic pathology market,” stated a FMI. “Our strategic insights and innovative methodologies empower us to drive and navigate growth within this evolving landscape, reinforcing our position as a key player in the industry.”
Key insights driving the growth of the anatomic pathology market include:
- Expanded Role in Disease Diagnosis: The increasing emphasis on accurate disease diagnosis is fueling demand for anatomic pathology services and solutions.
- Critical Contribution to Drug Discovery: The essential role that anatomic pathology plays in drug discovery and development is further propelling market expansion.
With its commitment to cutting-edge research and extensive industry expertise, Future Market Insights is well-equipped to harness the growth potential within the anatomic pathology market, ensuring that it remains at the forefront of innovation and excellence.
Key Takeaways: Anatomic Pathology Market Poised for Growth
- The global anatomic pathology market is expected to see significant growth, reaching USD 61.1 Billion by 2030 at a CAGR of 8.2%.
- The U.S. is projected to be a major player due to factors like rising cancer rates, high research funding, favorable reimbursement policies, and a strong presence of industry leaders.
- High investment in R&D for personalized medicine and chronic disease management strengthens the U.S. market position.
- An increase in chronic diseases and adoption of advanced pathology devices will drive Germany’s market growth.
- The European market, led by Germany and the U.K., is expected to hold a substantial share (25.7%) of the global market.
Soaring Demand for Market Information: Uncover Detailed Trends and Insights in Our Report!
Key Participant Insights:
The key market players are focusing on technological upgradations and expansion strategies to keep themselves fiercely competitive.
For instance:
- In Jul 2020, Bio SB tabled its Fast Mohs PolyDetector Plus Detection System, which comes across as a super sensitive nonbiotin monovalent Fab micropolymer immunohistochemistry system to detect IVD antibodies for squamous cell carcinoma, basal cell carcinoma, and melanoma.
- In Jan 2019, Quest Diagnostics announced completion of acquisition of the US laboratory services business that belonged to Oxford Immunotec (the T-Spot and Accutix tick-borne disease testing services, since then, are part of Quest’s infectious disease testing services.
- In 2018, Leica Microsystems entered into a collaboration with Thermo Fisher to develop an integrated cryotomography workflow with regards to research.
Key companies profiled:
- Laboratory Corporation of America Holdings
- Sakura Finetek USA, Inc.
- F.Hoffmann-La Roche AG
- Cardinal Health, Inc.
- BioGenex
- NeoGenomics
- Agilent Technologies
The US continues to be one of the leading markets for anatomic pathology industry globally. Strong presence of some of the leading players, combined with relatively easier funding for R&D will drive the US anatomic pathology industry during the assessment period.
The Europe anatomic pathology industry is also likely to grow at a brisk pace during the assessment period. The growth will remain concentrated in Western Europe, as has been the case traditionally.
Asia Pacific represents a high growth market for anatomic pathology stakeholders. Many countries in the region are renewing their focus on healthcare, as the current Covid-19 crisis has reinforced the necessity of a robust healthcare system.
Key Segments of Anatomic Pathology Industry Survey:
Anatomic Pathology Industry by Product & Service:
- Anatomic Pathology Instruments
- Anatomic Pathology Consumables
- Anatomic Pathology Services
Anatomic Pathology Industry by Application:
- Disease Diagnosis
- Drug Discovery and Development
- Others
Anatomic Pathology Industry by End User:
- Hospitals
- Research Laboratories
- Diagnostic Laboratories
- Others
Anatomic Pathology Industry by Region:
- North America Anatomic Pathology Industry
- Latin America Anatomic Pathology Industry
- Europe Anatomic Pathology Industry
- East Asia Anatomic Pathology Industry
- South Asia & Pacific Anatomic Pathology Industry
- Middle East & Africa (MEA) Anatomic Pathology Industry
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube